β‘ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Lifordi Immunotherapeutics just got measured.
4/10 means Lifordi Immunotherapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Overview Leadership Board of Directors Clinical Advisory Board Technology LFD-200 Pipeline Clinical Trials News/Events News Events Publications Contact Targeted Delivery Maximizing Therapeutic ImpactDeveloping new therapies for autoimmune and inflammatory disorders using a novel, targeted delivery platform Technology Lifordi Is Pioneering a Targeted Approach to Enhance Delivery to the Immune Syste
Industry: Technology
lifordi.com2
Structured Data
6
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
5
Technical AEO
3
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Lifordi Immunotherapeutics.
Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/lifordi
Cite this score: Engagemii (2026). "AEO Score for Lifordi Immunotherapeutics." Retrieved from https://engagemii.com/aeo/brands/lifordi
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform